title: [Immunoenzyme determination of fibrin-fibrinogen degradation product levels in acute myocardial infarct patients].
abstract: The changes in the blood level of fibrin-fibrinogen degradation products (FDP) have been studied in 62 patients with myocardial infarction. 30 healthy donors served as the control. FDP was determined using solid-phase immunoenzyme assay. Acute and subacute phases of myocardial infarction were characterized by an increase in FDP blood level. However, in severe cases a possible low FDP blood level in conditions of fibrinolysis depression may be associated with an increased risk of severe thromboembolic complications.
authors.forename: I A
authors.initials: IA
authors.lastname: Grinshteĭn
authors.forename: G V
authors.initials: GV
authors.lastname: Ignashenkova
authors.forename: M I
authors.initials: MI
authors.lastname: Kitaev
mesh_terms: D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis*; D005342:Fibrinolysis; D006801:Humans; D007124:Immunoenzyme Techniques; D009203:Myocardial Infarction / Q000097:blood*; D013997:Time Factors
chemical_list: D005338:Fibrin Fibrinogen Degradation Products
vernacular_title: Immunofermentnoe opredelenie kontsentratsii produktov degradatsii fibrin-fibrinogena u bol'nykh ostrym infarktom miokarda.